Saumya Pandey, DO
Family Practice · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 1 carrier
- Office
- 1
Offices
1 location · University Healthcare Alliance · 334 clinicians in this group
Looking this up.
Hospitals listed: 058415 · Good Samaritan Hospital · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
12 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Pandey’s office at (408) 426-5540 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$143,413
Medicare paid this office $143,413 for 361 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 279 | $63,632 | $110 |
| Long return visit (40+ min) | 76 | $19,896 | $162 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 40 | $11,591 | $290 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 71 | $10,869 | $153 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 301 | $9,975 | $14 |
See all 17 services
| Return visit (30+ min) | 279 | $63,632 | $110 |
| Long return visit (40+ min) | 76 | $19,896 | $162 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 40 | $11,591 | $290 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 71 | $10,869 | $153 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 301 | $9,975 | $14 |
| Short return visit (20+ min) | 69 | $6,138 | $76 |
| New patient visit (45+ min) | 39 | $4,192 | $107 |
| Influenza vaccine split virus, preservative free | 36 | $3,017 | $82 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 31 | $2,140 | $51 |
| Administration of influenza virus vaccine | 38 | $1,491 | $38 |
| Administration of pneumococcal vaccine | 39 | $1,491 | $38 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 11 | $1,122 | $40 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | 13 | $895 | $69 |
| Short return visit | 13 | $558 | $43 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 20 | $281 | $13 |
| Hemoglobin a1c level | 11 | $114 | $10 |
| Automated urinalysis test | 23 | $57 | $2 |
Who their Medicare patients are
361 Original Medicare patients in 2024. Average age 74 · Under 65 5% · 85 and older 9% · Women 73% · Also on Medicaid 9% · Health risk score 1.14. Above the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 62% · Cancer 22% · Depression 20% · Coronary heart disease 19% · Chronic kidney disease 16% · Diabetes 15% · Atrial fibrillation 13% · Heart failure 10% · COPD 9% · Stroke 7% · Dementia 6%.
The office billed $529,718, Medicare allowed $189,198 and paid $143,413; for 2,016 services of 41 kinds; $15,290 of it was for drugs given in the office and $128,123 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 361 | 2,016 | 74 | 1.14 | $529,718 | $143,413 |
| 2023 | 337 | 960 | 74 | 1.09 | $331,672 | $94,595 |
| 2022 | 303 | 873 | 74 | 1.11 | $296,003 | $87,950 |
| 2021 | 257 | 728 | 73 | 1.08 | $287,760 | $82,551 |
| 2020 | 233 | 669 | 73 | 1.05 | $242,424 | $55,222 |
| 2019 | 255 | 848 | 73 | 1.04 | $296,615 | $65,682 |
| 2018 | 455 | 1,674 | 72 | 1.23 | $235,928 | $61,253 |
| 2017 | 489 | 2,073 | 72 | 1.28 | $259,073 | $76,053 |
| 2016 | 159 | 532 | 73 | 1.35 | $59,845 | $19,828 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Return visit (30+ min) | 217 | $42,680 | $108 |
| Long return visit (40+ min) | 66 | $16,600 | $155 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 51 | $7,951 | $156 |
| Short return visit (20+ min) | 49 | $4,575 | $73 |
| Influenza vaccine split virus, preservative free | 60 | $4,312 | $72 |
| New patient visit (45+ min) | 33 | $4,261 | $129 |
| Administration of influenza virus vaccine | 63 | $2,328 | $37 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 18 | $1,337 | $51 |
| New patient visit (30+ min) | 12 | $1,143 | $95 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | 13 | $775 | $52 |
| Short return visit | 13 | $691 | $53 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 11 | $211 | $16 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 15 | $198 | $13 |
| Urinalysis, manual test | 14 | $48 | $3 |
2022: 12 services
| Return visit (30+ min) | 192 | $39,466 | $111 |
| Long return visit (40+ min) | 64 | $15,307 | $161 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 49 | $7,761 | $158 |
| Short return visit (20+ min) | 57 | $4,884 | $70 |
| Influenza vaccine split virus, preservative free | 64 | $4,387 | $69 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 12 | $3,351 | $279 |
| New patient visit (45+ min) | 23 | $2,704 | $118 |
| Administration of influenza virus vaccine | 68 | $2,532 | $37 |
| New patient visit (60+ min) | 11 | $2,125 | $193 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 11 | $726 | $52 |
| Administration of pneumococcal vaccine | 14 | $525 | $37 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 11 | $113 | $10 |
2021: 10 services
| Return visit (30+ min) | 170 | $36,468 | $112 |
| Long return visit (40+ min) | 78 | $22,643 | $176 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 37 | $6,054 | $164 |
| New patient visit (45+ min) | 24 | $3,472 | $145 |
| Short return visit (20+ min) | 39 | $3,250 | $72 |
| Pneumococcal vaccine, 23-valent | 12 | $1,499 | $125 |
| Influenza vaccine split virus, preservative free | 22 | $1,436 | $65 |
| Administration of influenza virus vaccine | 24 | $526 | $22 |
| Administration of pneumococcal vaccine | 15 | $327 | $22 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 12 | $164 | $14 |
2020: 10 services
| Return visit (30+ min) | 162 | $31,024 | $92 |
| Short return visit (20+ min) | 78 | $6,263 | $66 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 27 | $3,888 | $144 |
| Long return visit (40+ min) | 12 | $2,187 | $146 |
| Telephone medical discussion with physician, 11-20 minutes | 24 | $2,058 | $74 |
| Pneumococcal vaccine, 23-valent | 15 | $1,783 | $119 |
| Influenza vaccine split virus, preservative free | 26 | $1,579 | $61 |
| New patient visit (30+ min) | 13 | $652 | $50 |
| Administration of influenza virus vaccine | 28 | $585 | $21 |
| Administration of pneumococcal vaccine | 20 | $417 | $21 |
2019: 12 services
| Return visit (30+ min) | 177 | $34,676 | $89 |
| Short return visit (20+ min) | 86 | $8,069 | $63 |
| Pneumococcal vaccine, 13-valent | 24 | $5,014 | $209 |
| New patient visit (45+ min) | 42 | $4,851 | $115 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 29 | $4,033 | $139 |
| Influenza vaccine split virus, preservative free | 33 | $1,811 | $55 |
| Pneumococcal vaccine, 23-valent | 16 | $1,759 | $110 |
| New patient visit (30+ min) | 16 | $1,386 | $87 |
| Administration of influenza virus vaccine | 44 | $902 | $21 |
| Administration of pneumococcal vaccine | 40 | $820 | $21 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 11 | $205 | $19 |
| Urinalysis, manual test | 17 | $65 | $3 |
2018: 24 services
| Return visit (30+ min) | 237 | $23,748 | $72 |
| Short return visit (20+ min) | 214 | $11,752 | $44 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 29 | $3,704 | $128 |
| Influenza vaccine split virus, preservative free | 57 | $2,964 | $52 |
| Pneumococcal vaccine, 13-valent | 13 | $2,564 | $197 |
| New patient visit (45+ min) | 15 | $2,297 | $153 |
| Administration of influenza virus vaccine | 62 | $1,579 | $25 |
| Blood test, lipids (cholesterol and triglycerides) | 74 | $1,296 | $16 |
| Blood test, basic group of blood chemicals (calcium, total) | 96 | $1,176 | $10 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 92 | $884 | $9 |
| New patient visit (30+ min) | 17 | $879 | $52 |
| Hemoglobin a1c level | 48 | $752 | $12 |
| Vitamin d-3 level | 13 | $466 | $36 |
| Insertion of needle into vein for collection of blood sample | 126 | $444 | $3 |
| Administration of pneumococcal vaccine | 17 | $406 | $24 |
| Blood test, thyroid stimulating hormone (tsh) | 19 | $386 | $20 |
| Short return visit | 14 | $379 | $27 |
| Injection of drug or substance under skin or into muscle | 18 | $281 | $15 |
| Blood test, comprehensive group of blood chemicals | 20 | $256 | $13 |
| Manual urinalysis test with examination using microscope, automated | 41 | $169 | $4 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 13 | $165 | $13 |
| Thyroxine (thyroid chemical), free | 14 | $153 | $11 |
| Ldl cholesterol level | 11 | $150 | $12 |
| Automated urinalysis test | 31 | $87 | $3 |
2017: 29 services
| Return visit (30+ min) | 248 | $31,621 | $74 |
| Short return visit (20+ min) | 212 | $13,201 | $51 |
| New patient visit (30+ min) | 72 | $4,687 | $65 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 17 | $3,006 | $177 |
| New patient visit (45+ min) | 28 | $2,947 | $105 |
| Pneumococcal vaccine, 13-valent | 12 | $2,020 | $168 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 13 | $1,562 | $120 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 121 | $1,391 | $10 |
| Blood test, lipids (cholesterol and triglycerides) | 83 | $1,376 | $15 |
| Blood test, basic group of blood chemicals (calcium, total) | 94 | $1,171 | $10 |
| Blood test, thyroid stimulating hormone (tsh) | 42 | $994 | $23 |
| Influenza vaccine split virus, preservative free | 20 | $961 | $48 |
| Vitamin d-3 level | 23 | $915 | $40 |
| Hemoglobin a1c level | 45 | $900 | $13 |
| Injection of drug or substance under skin or into muscle | 32 | $832 | $20 |
| Blood test, comprehensive group of blood chemicals | 52 | $620 | $11 |
| Administration of influenza virus vaccine | 23 | $619 | $27 |
| Insertion of needle into vein for collection of blood sample | 149 | $576 | $3 |
| Short return visit | 18 | $562 | $31 |
| Thyroxine (thyroid chemical), free | 39 | $485 | $12 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 14 | $356 | $15 |
| Administration of pneumococcal vaccine | 12 | $323 | $27 |
| Manual urinalysis test with examination using microscope, automated | 69 | $316 | $4 |
| Urine microalbumin (protein) level | 20 | $171 | $8 |
| Creatinine level to test for kidney function or muscle injury | 20 | $153 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 12 | $141 | $12 |
| Bacterial colony count, urine | 11 | $119 | $11 |
| Stool analysis for blood to screen for colon tumors | 16 | $70 | $4 |
| Injection, ketorolac tromethamine, per 15 mg | 14 | $14 | None |
2016: 15 services
| Return visit (30+ min) | 65 | $6,238 | $83 |
| Short return visit (20+ min) | 61 | $4,175 | $58 |
| New patient visit (30+ min) | 20 | $1,591 | $80 |
| New patient visit (15+ min) | 23 | $1,297 | $56 |
| Influenza vaccine split virus, preservative free | 19 | $764 | $40 |
| Administration of influenza virus vaccine | 23 | $610 | $27 |
| Blood test, thyroid stimulating hormone (tsh) | 16 | $359 | $22 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 28 | $291 | $10 |
| Blood test, comprehensive group of blood chemicals | 23 | $280 | $12 |
| Blood test, lipids (cholesterol and triglycerides) | 21 | $279 | $13 |
| Thyroxine (thyroid chemical), free | 15 | $180 | $12 |
| Hemoglobin a1c level | 12 | $156 | $13 |
| Insertion of needle into vein for collection of blood sample | 40 | $121 | $3 |
| Blood test, basic group of blood chemicals (calcium, total) | 12 | $114 | $9 |
| Manual urinalysis test with examination using microscope, automated | 19 | $85 | $4 |
Medicaid work
$3,625 in 2018
Medicaid paid $3,625 for 489 billed services this clinician did in 2018, up to 49 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 284 | $2,321 |
| Short return visit (20+ min) | 193 | $1,227 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 12 | $77 |
| 2018 | 489 | 3 | 49 | $3,625 |
Drugs they prescribed that Part D paid
$182,682
Pharmacies billed $182,682 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (76 of 2,917) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%. Long-acting opioids: 18% of their opioid prescriptions.
2,609 generic and fewer than 11 brand-name prescriptions · $182,682 in drug cost · 92 antibiotic prescriptions to 72 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 43 | $34,304 | $798 |
| Xarelto | 18 | $14,934 | $830 |
| Breo Ellipta | 18 | $6,649 | $369 |
| Gemtesa | 12 | $5,692 | $474 |
| Testosterone | 11 | $5,033 | $458 |
See all 73 drugs
| Eliquis | 43 | $34,304 | $798 |
| Xarelto | 18 | $14,934 | $830 |
| Breo Ellipta | 18 | $6,649 | $369 |
| Gemtesa | 12 | $5,692 | $474 |
| Testosterone | 11 | $5,033 | $458 |
| Qvar Redihaler | 12 | $3,452 | $288 |
| Rosuvastatin | 120 | $2,370 | $20 |
| Synthroid | 27 | $2,262 | $84 |
| Atorvastatin | 223 | $1,664 | $7 |
| Levothyroxine | 126 | $1,584 | $13 |
| Pregabalin | 22 | $1,525 | $69 |
| Gabapentin | 100 | $1,521 | $15 |
| Omeprazole | 56 | $1,341 | $24 |
| Duloxetine | 27 | $1,270 | $47 |
| Hydrocodone-Acetaminophen | 39 | $960 | $25 |
| Losartan | 86 | $942 | $11 |
| Tamsulosin | 38 | $832 | $22 |
| Albuterol Sulfate Hfa | 24 | $790 | $33 |
| Venlafaxine Hcl Er | 26 | $782 | $30 |
| Colesevelam | 11 | $743 | $68 |
| Amlodipine Besylate | 111 | $738 | $7 |
| Celecoxib | 11 | $718 | $65 |
| Lisinopril | 85 | $707 | $8 |
| Olmesartan-Hydrochlorothiazide | 13 | $624 | $48 |
| Metoprolol | 34 | $616 | $18 |
| Hydroxyzine | 15 | $596 | $40 |
| Diltiazem | 11 | $571 | $52 |
| Morphine Sulfate Er | 12 | $559 | $47 |
| Diclofenac | 14 | $481 | $34 |
| Bupropion Xl | 21 | $455 | $22 |
| Digoxin | 12 | $433 | $36 |
| Escitalopram | 23 | $398 | $17 |
| Dantrolene | 11 | $389 | $35 |
| Sertraline | 42 | $367 | $9 |
| Alprazolam | 77 | $366 | $5 |
| Zolpidem | 37 | $347 | $9 |
| Ezetimibe | 14 | $339 | $24 |
| Trazodone | 29 | $322 | $11 |
| Propranolol | 14 | $279 | $20 |
| Simvastatin | 36 | $269 | $7 |
| Pantoprazole | 26 | $264 | $10 |
| Carbidopa-Levodopa Er | 18 | $255 | $14 |
| Tizanidine | 15 | $252 | $17 |
| Nitrofurantoin Mono-Macro | 19 | $248 | $13 |
| Montelukast | 20 | $245 | $12 |
| Clopidogrel | 23 | $239 | $10 |
| Metformin | 44 | $208 | $5 |
| Atenolol | 13 | $205 | $16 |
| Sumatriptan | 20 | $197 | $10 |
| Nystatin | 11 | $193 | $18 |
| Fluticasone Propionate | 19 | $191 | $10 |
| Temazepam | 20 | $180 | $9 |
| Amiodarone | 11 | $174 | $16 |
| Citalopram Hbr | 16 | $162 | $10 |
| Potassium Chloride | 17 | $160 | $9 |
| Famotidine | 23 | $150 | $7 |
| Hydrochlorothiazide | 26 | $144 | $6 |
| Triamcinolone Acetonide | 17 | $138 | $8 |
| Alendronate | 17 | $121 | $7 |
| Pravastatin | 13 | $119 | $9 |
| Lisinopril-Hydrochlorothiazide | 21 | $119 | $6 |
| Amoxicillin-Clavulanate Potass | 14 | $113 | $8 |
| Azithromycin | 23 | $105 | $5 |
| Ciprofloxacin | 16 | $104 | $7 |
| Diazepam | 11 | $100 | $9 |
| Furosemide | 18 | $92 | $5 |
| Metoprolol | 30 | $92 | $3 |
| Lorazepam | 33 | $85 | $3 |
| Losartan-Hydrochlorothiazide | 17 | $82 | $5 |
| Meclizine | 11 | $71 | $6 |
| Acetaminophen-Codeine | 11 | $67 | $6 |
| Metformin Hcl Er | 28 | $38 | $1 |
| Clonazepam | 12 | $8 | $1 |
Year by year
| 2024 | 2,917 | 375 | 3% (76) | None | $182,682 |
| 2023 | 2,522 | 382 | 3% (62) | 10% | $153,464 |
| 2022 | 2,169 | 343 | 3% (55) | 9% | $125,821 |
| 2021 | 1,947 | 291 | 3% (63) | None | $119,302 |
| 2020 | 1,978 | 276 | 3% (60) | None | $114,224 |
| 2019 | 1,800 | 283 | 4% (64) | None | $123,041 |
| 2018 | 2,401 | 439 | 2% (58) | 13% | $146,147 |
| 2017 | 2,050 | 375 | 5% (94) | 15% | $139,523 |
| 2016 | 262 | 86 | 8% (20) | 17% | $15,282 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 60 drugs
| Eliquis | 32 | $27,491 | $859 |
| Advair Diskus | 13 | $8,186 | $630 |
| Cyclosporine | 15 | $5,096 | $340 |
| Rosuvastatin | 83 | $3,447 | $42 |
| Atorvastatin | 210 | $2,494 | $12 |
| Levothyroxine | 147 | $1,994 | $14 |
| Synthroid | 15 | $1,512 | $101 |
| Losartan | 102 | $1,490 | $15 |
| Metoprolol | 54 | $1,231 | $23 |
| Duloxetine | 23 | $1,081 | $47 |
| Albuterol Sulfate Hfa | 18 | $831 | $46 |
| Amlodipine Besylate | 121 | $756 | $6 |
| Celecoxib | 11 | $729 | $66 |
| Gabapentin | 77 | $704 | $9 |
| Tamsulosin | 36 | $696 | $19 |
| Lisinopril | 79 | $613 | $8 |
| Eszopiclone | 12 | $600 | $50 |
| Escitalopram | 31 | $565 | $18 |
| Sertraline | 32 | $520 | $16 |
| Ipratropium | 14 | $490 | $35 |
| Metformin | 50 | $478 | $10 |
| Omeprazole | 41 | $460 | $11 |
| Propranolol | 13 | $449 | $35 |
| Olmesartan-Hydrochlorothiazide | 12 | $432 | $36 |
| Fluticasone Propionate | 22 | $426 | $19 |
| Potassium Chloride | 15 | $416 | $28 |
| Sumatriptan | 19 | $400 | $21 |
| Nitrofurantoin Mono-Macro | 16 | $314 | $20 |
| Alprazolam | 50 | $296 | $6 |
| Zolpidem | 39 | $285 | $7 |
| Hydrocodone-Acetaminophen | 24 | $264 | $11 |
| Losartan-Hydrochlorothiazide | 11 | $257 | $23 |
| Ezetimibe | 12 | $249 | $21 |
| Tizanidine | 15 | $249 | $17 |
| Clonazepam | 16 | $247 | $15 |
| Temazepam | 23 | $234 | $10 |
| Hydrochlorothiazide | 43 | $220 | $5 |
| Lisinopril-Hydrochlorothiazide | 26 | $176 | $7 |
| Trazodone | 32 | $174 | $5 |
| Carvedilol | 17 | $171 | $10 |
| Alendronate | 16 | $169 | $11 |
| Pravastatin | 13 | $166 | $13 |
| Azithromycin | 26 | $159 | $6 |
| Famotidine | 12 | $155 | $13 |
| Furosemide | 22 | $151 | $7 |
| Clopidogrel | 12 | $144 | $12 |
| Simvastatin | 22 | $141 | $6 |
| Triamcinolone Acetonide | 19 | $138 | $7 |
| Paxlovid (Eua) | 12 | $119 | $10 |
| Lorazepam | 32 | $107 | $3 |
| Prednisone | 11 | $100 | $9 |
| Metformin Hcl Er | 17 | $93 | $5 |
| Citalopram Hbr | 23 | $88 | $4 |
| Atenolol | 12 | $88 | $7 |
| Carisoprodol | 13 | $83 | $6 |
| Pantoprazole | 12 | $82 | $7 |
| Metoprolol | 20 | $79 | $4 |
| Meloxicam | 12 | $72 | $6 |
| Quetiapine | 11 | $52 | $5 |
| Lovastatin | 12 | $24 | $2 |
2022: 50 drugs
| Xarelto | 15 | $12,385 | $826 |
| Rivastigmine | 11 | $4,918 | $447 |
| Atorvastatin | 177 | $2,302 | $13 |
| Rosuvastatin | 47 | $2,018 | $43 |
| Levothyroxine | 114 | $1,990 | $17 |
| Olmesartan-Hydrochlorothiazide | 13 | $1,629 | $125 |
| Gabapentin | 63 | $1,465 | $23 |
| Duloxetine | 24 | $1,128 | $47 |
| Metoprolol | 50 | $1,098 | $22 |
| Albuterol Sulfate Hfa | 16 | $966 | $60 |
| Pregabalin | 17 | $959 | $56 |
| Ezetimibe | 16 | $875 | $55 |
| Potassium Chloride | 12 | $828 | $69 |
| Losartan | 63 | $809 | $13 |
| Omeprazole | 39 | $706 | $18 |
| Amlodipine Besylate | 87 | $662 | $8 |
| Fluticasone Propionate | 39 | $658 | $17 |
| Lisinopril | 96 | $512 | $5 |
| Escitalopram | 21 | $458 | $22 |
| Sertraline | 42 | $448 | $11 |
| Tamsulosin | 31 | $411 | $13 |
| Pravastatin | 19 | $400 | $21 |
| Pantoprazole | 20 | $393 | $20 |
| Metformin | 55 | $383 | $7 |
| Alprazolam | 50 | $370 | $7 |
| Hydrocodone-Acetaminophen | 25 | $318 | $13 |
| Temazepam | 20 | $300 | $15 |
| Finasteride | 11 | $261 | $24 |
| Sumatriptan | 16 | $253 | $16 |
| Zolpidem | 32 | $238 | $7 |
| Nitrofurantoin Mono-Macro | 12 | $218 | $18 |
| Montelukast | 13 | $202 | $16 |
| Hydrochlorothiazide | 35 | $197 | $6 |
| Trazodone | 21 | $184 | $9 |
| Famotidine | 12 | $165 | $14 |
| Prednisone | 15 | $149 | $10 |
| Alendronate | 12 | $134 | $11 |
| Atenolol | 19 | $129 | $7 |
| Citalopram Hbr | 13 | $129 | $10 |
| Carvedilol | 18 | $123 | $7 |
| Paxlovid (Eua) | 11 | $99 | $9 |
| Lisinopril-Hydrochlorothiazide | 16 | $95 | $6 |
| Simvastatin | 24 | $94 | $4 |
| Azithromycin | 17 | $92 | $5 |
| Carisoprodol | 11 | $79 | $7 |
| Clonidine | 11 | $79 | $7 |
| Lorazepam | 27 | $73 | $3 |
| Ciprofloxacin | 14 | $68 | $5 |
| Furosemide | 13 | $64 | $5 |
| Cyclobenzaprine | 13 | $40 | $3 |
2021: 49 drugs
| Levothyroxine | 103 | $2,274 | $22 |
| Potassium Chloride | 17 | $2,267 | $133 |
| Atorvastatin | 140 | $1,917 | $14 |
| Pregabalin | 32 | $1,882 | $59 |
| Synthroid | 19 | $1,628 | $86 |
| Gabapentin | 46 | $1,147 | $25 |
| Rosuvastatin | 30 | $1,120 | $37 |
| Metoprolol | 49 | $1,120 | $23 |
| Olmesartan-Hydrochlorothiazide | 13 | $969 | $75 |
| Losartan | 58 | $895 | $15 |
| Ezetimibe | 14 | $883 | $63 |
| Duloxetine | 25 | $818 | $33 |
| Omeprazole | 26 | $807 | $31 |
| Lisinopril | 86 | $744 | $9 |
| Escitalopram | 31 | $659 | $21 |
| Losartan-Hydrochlorothiazide | 16 | $647 | $40 |
| Isosorbide Dinitrate | 12 | $640 | $53 |
| Amlodipine Besylate | 75 | $625 | $8 |
| Pravastatin | 24 | $585 | $24 |
| Sertraline | 43 | $383 | $9 |
| Diclofenac | 11 | $358 | $33 |
| Famotidine | 26 | $329 | $13 |
| Oxycodone-Acetaminophen | 11 | $314 | $29 |
| Metformin | 42 | $292 | $7 |
| Pantoprazole | 22 | $287 | $13 |
| Montelukast | 18 | $262 | $15 |
| Lovastatin | 16 | $247 | $15 |
| Zolpidem | 34 | $243 | $7 |
| Fluticasone Propionate | 24 | $233 | $10 |
| Atenolol | 17 | $211 | $12 |
| Hydrochlorothiazide | 34 | $190 | $6 |
| Morphine Sulfate Er | 21 | $189 | $9 |
| Tamsulosin | 15 | $153 | $10 |
| Baclofen | 11 | $144 | $13 |
| Ibuprofen | 11 | $139 | $13 |
| Carvedilol | 14 | $133 | $9 |
| Trazodone | 27 | $132 | $5 |
| Triamcinolone Acetonide | 13 | $131 | $10 |
| Naproxen | 14 | $117 | $8 |
| Temazepam | 16 | $114 | $7 |
| Alprazolam | 21 | $101 | $5 |
| Alendronate | 13 | $86 | $7 |
| Carisoprodol | 12 | $82 | $7 |
| Clonazepam | 14 | $79 | $6 |
| Simvastatin | 22 | $79 | $4 |
| Hydrocodone-Acetaminophen | 13 | $79 | $6 |
| Furosemide | 19 | $78 | $4 |
| Ciprofloxacin | 15 | $61 | $4 |
| Lorazepam | 13 | $43 | $3 |
2020: 55 drugs
| Eliquis | 11 | $5,650 | $514 |
| Levothyroxine | 119 | $2,716 | $23 |
| Atorvastatin | 118 | $1,984 | $17 |
| Synthroid | 25 | $1,642 | $66 |
| Gabapentin | 39 | $1,275 | $33 |
| Ezetimibe | 12 | $1,213 | $101 |
| Pregabalin | 20 | $1,194 | $60 |
| Losartan | 66 | $1,181 | $18 |
| Dantrolene | 12 | $1,158 | $96 |
| Albuterol Sulfate Hfa | 14 | $888 | $63 |
| Lisinopril | 87 | $745 | $9 |
| Metoprolol | 35 | $731 | $21 |
| Pravastatin | 21 | $686 | $33 |
| Duloxetine | 21 | $674 | $32 |
| Omeprazole | 28 | $655 | $23 |
| Diclofenac | 17 | $650 | $38 |
| Amlodipine Besylate | 72 | $631 | $9 |
| Olmesartan-Hydrochlorothiazide | 12 | $622 | $52 |
| Isosorbide Dinitrate | 15 | $616 | $41 |
| Rosuvastatin | 26 | $512 | $20 |
| Lovastatin | 17 | $480 | $28 |
| Escitalopram | 29 | $430 | $15 |
| Pantoprazole | 23 | $422 | $18 |
| Sertraline | 50 | $420 | $8 |
| Zolpidem | 44 | $329 | $7 |
| Oxycodone-Acetaminophen | 11 | $317 | $29 |
| Donepezil | 15 | $312 | $21 |
| Metformin | 44 | $299 | $7 |
| Trazodone | 26 | $283 | $11 |
| Hydrochlorothiazide | 48 | $280 | $6 |
| Simvastatin | 40 | $256 | $6 |
| Atenolol | 21 | $211 | $10 |
| Metoprolol | 12 | $210 | $18 |
| Montelukast | 17 | $209 | $12 |
| Doxepin | 14 | $202 | $14 |
| Alendronate | 22 | $186 | $8 |
| Morphine Sulfate Er | 20 | $182 | $9 |
| Ibuprofen | 18 | $170 | $9 |
| Hydralazine | 16 | $142 | $9 |
| Carvedilol | 13 | $127 | $10 |
| Fluticasone Propionate | 11 | $125 | $11 |
| Metformin Hcl Er | 11 | $119 | $11 |
| Temazepam | 13 | $109 | $8 |
| Triamcinolone Acetonide | 20 | $108 | $5 |
| Furosemide | 23 | $106 | $5 |
| Clopidogrel | 14 | $101 | $7 |
| Azithromycin | 12 | $95 | $8 |
| Famotidine | 11 | $93 | $8 |
| Hydrocodone-Acetaminophen | 15 | $91 | $6 |
| Carisoprodol | 14 | $91 | $7 |
| Naproxen | 13 | $76 | $6 |
| Ciprofloxacin | 13 | $73 | $6 |
| Clonazepam | 12 | $68 | $6 |
| Alprazolam | 16 | $62 | $4 |
| Lorazepam | 14 | $22 | $2 |
2019: 45 drugs
| Lyrica | 14 | $12,453 | $889 |
| Levothyroxine | 104 | $2,530 | $24 |
| Synthroid | 19 | $1,788 | $94 |
| Rosuvastatin | 31 | $1,723 | $56 |
| Atorvastatin | 91 | $1,451 | $16 |
| Metoprolol | 27 | $1,068 | $40 |
| Lisinopril | 90 | $780 | $9 |
| Losartan | 54 | $707 | $13 |
| Methylphenidate | 12 | $634 | $53 |
| Pregabalin | 12 | $634 | $53 |
| Escitalopram | 27 | $566 | $21 |
| Pantoprazole | 24 | $519 | $22 |
| Omeprazole | 18 | $512 | $28 |
| Oxycodone-Acetaminophen | 12 | $484 | $40 |
| Montelukast | 25 | $478 | $19 |
| Pravastatin | 12 | $468 | $39 |
| Amlodipine Besylate | 61 | $465 | $8 |
| Duloxetine | 14 | $427 | $30 |
| Gabapentin | 19 | $376 | $20 |
| Simvastatin | 34 | $370 | $11 |
| Diphenoxylate-Atropine | 19 | $359 | $19 |
| Zolpidem | 49 | $353 | $7 |
| Isosorbide Dinitrate | 11 | $334 | $30 |
| Atenolol | 30 | $331 | $11 |
| Trazodone | 40 | $321 | $8 |
| Clopidogrel | 16 | $320 | $20 |
| Metformin | 30 | $314 | $10 |
| Sertraline | 29 | $262 | $9 |
| Lovastatin | 12 | $225 | $19 |
| Tramadol | 16 | $212 | $13 |
| Naproxen | 19 | $208 | $11 |
| Hydrochlorothiazide | 33 | $203 | $6 |
| Valacyclovir | 11 | $201 | $18 |
| Morphine Sulfate Er | 21 | $201 | $10 |
| Baclofen | 14 | $183 | $13 |
| Ibuprofen | 17 | $166 | $10 |
| Triamcinolone Acetonide | 16 | $125 | $8 |
| Ciprofloxacin | 21 | $121 | $6 |
| Azithromycin | 23 | $119 | $5 |
| Famotidine | 13 | $118 | $9 |
| Alendronate | 12 | $113 | $9 |
| Lorazepam | 25 | $112 | $4 |
| Lisinopril-Hydrochlorothiazide | 11 | $96 | $9 |
| Metformin Hcl Er | 11 | $95 | $9 |
| Carisoprodol | 12 | $86 | $7 |
2018: 53 drugs
| Januvia | 23 | $11,771 | $512 |
| Lantus Solostar | 13 | $6,807 | $524 |
| Advair Diskus | 12 | $5,392 | $449 |
| Atorvastatin | 160 | $2,691 | $17 |
| Metoprolol | 40 | $1,522 | $38 |
| Levothyroxine | 73 | $1,511 | $21 |
| Metformin | 135 | $1,212 | $9 |
| Ezetimibe | 11 | $1,089 | $99 |
| Celecoxib | 11 | $1,027 | $93 |
| Ventolin Hfa | 11 | $993 | $90 |
| Rosuvastatin | 36 | $931 | $26 |
| Lisinopril | 135 | $863 | $6 |
| Losartan | 59 | $841 | $14 |
| Duloxetine | 22 | $690 | $31 |
| Escitalopram | 43 | $674 | $16 |
| Amlodipine Besylate | 72 | $627 | $9 |
| Pantoprazole | 48 | $606 | $13 |
| Metolazone | 12 | $560 | $47 |
| Potassium Chloride | 26 | $442 | $17 |
| Omeprazole | 39 | $400 | $10 |
| Pravastatin | 18 | $395 | $22 |
| Losartan-Hydrochlorothiazide | 26 | $390 | $15 |
| Simvastatin | 42 | $384 | $9 |
| Gabapentin | 33 | $380 | $12 |
| Tamsulosin | 15 | $345 | $23 |
| Carvedilol | 28 | $343 | $12 |
| Hydrochlorothiazide | 45 | $326 | $7 |
| Spironolactone | 12 | $315 | $26 |
| Montelukast | 22 | $314 | $14 |
| Valsartan-Hydrochlorothiazide | 12 | $312 | $26 |
| Clopidogrel | 17 | $302 | $18 |
| Glipizide Er | 14 | $239 | $17 |
| Trazodone | 27 | $200 | $7 |
| Tramadol | 30 | $193 | $6 |
| Ciprofloxacin | 32 | $171 | $5 |
| Alprazolam | 38 | $169 | $4 |
| Fluticasone Propionate | 14 | $166 | $12 |
| Hydralazine | 18 | $159 | $9 |
| Warfarin | 11 | $148 | $13 |
| Alendronate | 12 | $146 | $12 |
| Ondansetron | 19 | $128 | $7 |
| Naproxen | 21 | $124 | $6 |
| Citalopram Hbr | 16 | $121 | $8 |
| Lisinopril-Hydrochlorothiazide | 22 | $120 | $5 |
| Gemfibrozil | 12 | $117 | $10 |
| Metoprolol | 23 | $115 | $5 |
| Glipizide | 16 | $112 | $7 |
| Sertraline | 13 | $112 | $9 |
| Zolpidem | 14 | $97 | $7 |
| Atenolol | 14 | $82 | $6 |
| Meloxicam | 12 | $77 | $6 |
| Sulfamethoxazole-Trimethoprim | 19 | $71 | $4 |
| Furosemide | 28 | $66 | $2 |
2017: 54 drugs
| Advair Diskus | 25 | $9,017 | $361 |
| Atorvastatin | 107 | $1,724 | $16 |
| Ventolin Hfa | 22 | $1,656 | $75 |
| Celecoxib | 14 | $1,531 | $109 |
| Levothyroxine | 40 | $1,119 | $28 |
| Fluoxetine | 13 | $976 | $75 |
| Proair Hfa | 17 | $958 | $56 |
| Metformin | 80 | $775 | $10 |
| Duloxetine | 19 | $759 | $40 |
| Lisinopril | 99 | $737 | $7 |
| Hydrocodone-Acetaminophen | 41 | $708 | $17 |
| Metoprolol | 19 | $606 | $32 |
| Valsartan | 15 | $579 | $39 |
| Pantoprazole | 46 | $531 | $12 |
| Potassium Chloride | 37 | $501 | $14 |
| Escitalopram | 40 | $495 | $12 |
| Omeprazole | 32 | $429 | $13 |
| Gabapentin | 47 | $378 | $8 |
| Hydrochlorothiazide | 44 | $350 | $8 |
| Rosuvastatin | 11 | $347 | $32 |
| Losartan | 44 | $346 | $8 |
| Montelukast | 13 | $301 | $23 |
| Simvastatin | 32 | $291 | $9 |
| Fluticasone Propionate | 21 | $267 | $13 |
| Losartan-Hydrochlorothiazide | 12 | $264 | $22 |
| Lisinopril-Hydrochlorothiazide | 21 | $246 | $12 |
| Pioglitazone | 13 | $243 | $19 |
| Naproxen | 34 | $229 | $7 |
| Ranitidine | 19 | $220 | $12 |
| Amlodipine Besylate | 41 | $211 | $5 |
| Glipizide Er | 11 | $191 | $17 |
| Trazodone | 31 | $176 | $6 |
| Tizanidine | 11 | $175 | $16 |
| Ciprofloxacin | 22 | $164 | $7 |
| Valsartan-Hydrochlorothiazide | 12 | $161 | $13 |
| Famotidine | 28 | $150 | $5 |
| Clonazepam | 19 | $140 | $7 |
| Donepezil | 12 | $139 | $12 |
| Levofloxacin | 16 | $135 | $8 |
| Tramadol | 28 | $133 | $5 |
| Carvedilol | 19 | $127 | $7 |
| Glipizide | 15 | $126 | $8 |
| Furosemide | 31 | $117 | $4 |
| Alprazolam | 29 | $111 | $4 |
| Atenolol | 14 | $110 | $8 |
| Azithromycin | 18 | $100 | $6 |
| Acetaminophen-Codeine | 14 | $100 | $7 |
| Ondansetron | 16 | $79 | $5 |
| Meclizine | 11 | $77 | $7 |
| Metoprolol | 17 | $75 | $4 |
| Sulfamethoxazole-Trimethoprim | 16 | $59 | $4 |
| Zolpidem | 11 | $51 | $5 |
| Diazepam | 13 | $44 | $3 |
| Citalopram Hbr | 13 | $43 | $3 |
2016: 2 drugs
| Atorvastatin | 12 | $206 | $17 |
| Hydrocodone-Acetaminophen | 11 | $160 | $15 |
Money from drug and device companies
$40 in 2023
| 2023 | 1 | 1 | None | $40 |
| 2020 | 1 | 1 | None | $20 |
| 2019 | 2 | 2 | None | $32 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Senseonics | Eversense | $40 | 1 payment
|
See the published payment
| Senseonics | Meals · 2023-07-26 | Eversense | $40 |
See earlier years (2020, 2019)
2020: $20
| Silk Road Medical | Enroute Transcarotid Neuroprotection System | $20 | 1 payment
|
2019: $32
| Astellas Pharma US | Myrbetriq | $19 | 1 payment
|
| Hologic | Thinprep | $13 | 1 payment
|
Professional record
- NPI
- 1942671904
- Licence
- CA 20A13744
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 14251 Winchester Blvd Ste 200, Los Gatos, CA, 95032
- NPI first listed
- 2015-10-15
- NPI last updated
- 2024-04-15
- NPI record certified
- 2024-04-15
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 355 Abbott St, Salinas, CA, 93901